The Authors' Reply

Abstract

Cost-effectiveness, Cost-utility, Pioglitazone, Rosiglitazone, Type-2-diabetes-mellitus

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Last time updated on 14/01/2014